16:54 EST Xeris Biopharma (XERS) files $250M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XERS:
- Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
- Xeris Biopharma sees FY25 revenue $255M-$275M, consensus $239.77M
- XERS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Xeris Pharmaceuticals Appoints New Chief Medical Officer
- Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed